Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.
about
Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells.Cardiac spheroids as promising in vitro models to study the human heart microenvironment.Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery.Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability.Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification.Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening.Current Technologies Based on the Knowledge of the Stem Cells Microenvironments.Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms.Co-Differentiation of Human Pluripotent Stem Cells-Derived Cardiomyocytes and Endothelial Cells from Cardiac Mesoderm Provides a Three-Dimensional Model of Cardiac Microtissue.Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis.Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair.Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications.Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits
P2860
Q37711224-A487CB70-241A-490C-BF0F-1C6850534FD5Q38647934-04098A98-03D0-4BCD-84BE-EF3ABE085BC6Q38819976-97BF2558-110E-44AC-B75D-35F94B4F5C3BQ39030459-A452F744-7F84-4AB5-AC47-306D1CB32C32Q39345477-6EDBAE28-9C34-4DC8-A6B1-F7A9F67A953AQ39472056-E6AC43C3-A1F1-41B5-B0E4-E56E847B202AQ45944962-F63066CA-E5ED-46D1-999E-E29A44CD88FAQ46375849-31C463DD-3BD4-4147-8960-D8BB4F73D626Q47284554-F6DDF0F0-3328-46A6-B56C-062DF91313A0Q47557278-2EB30AE4-FAFA-40CA-963D-B17F6AA1F793Q50087955-60759C8E-BABD-4173-AA77-9195CBB64419Q50201254-D900FC3F-7D30-424F-84F9-801FD8C2D54FQ55287570-B73F0D59-8F6A-49F9-B48C-D006BB90BB0EQ55499094-E7716EAF-FB31-40A4-AF11-A73C03E677F0Q58577756-682FC81C-33B3-4846-818A-9A69B8A7D750
P2860
Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Cardiac Non-myocyte Cells Show ...... ed Cardiomyocyte Microtissues.
@en
Cardiac Non-myocyte Cells Show ...... ed Cardiomyocyte Microtissues.
@nl
type
label
Cardiac Non-myocyte Cells Show ...... ed Cardiomyocyte Microtissues.
@en
Cardiac Non-myocyte Cells Show ...... ed Cardiomyocyte Microtissues.
@nl
prefLabel
Cardiac Non-myocyte Cells Show ...... ed Cardiomyocyte Microtissues.
@en
Cardiac Non-myocyte Cells Show ...... ed Cardiomyocyte Microtissues.
@nl
P2093
P2860
P356
P1476
Cardiac Non-myocyte Cells Show ...... ed Cardiomyocyte Microtissues.
@en
P2093
Amy Pointon
Awel W Williams
James E Sidaway
Michael J Cross
Stephanie M Ravenscroft
P2860
P304
P356
10.1093/TOXSCI/KFW069
P577
2016-04-28T00:00:00Z